Return to search results
Carvedilol
Carvedilol is a prescription medication that acts as both an alpha and beta blocker to help manage high blood pressure, heart failure, and certain heart conditions by relaxing blood vessels and slowing heart rate. Available as oral tablets in strengths of 3.125 mg, 6.25 mg, 12.5 mg, and 25 mg, it's a generic version approved under ANDA078165. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Carvedilol is a prescription medication that acts as both an alpha and beta blocker to help manage high blood pressure, heart failure, and certain heart conditions by relaxing blood vessels and slowing heart rate. Available as oral tablets in strengths of 3.125 mg, 6.25 mg, 12.5 mg, and 25 mg, it's a generic version approved under ANDA078165. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Carvedilol",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Carvedilol — ANDA 078227 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078227"
}
]
|
| identifier | ANDA078227 |
| issued | 2016-09-16 |
| keyword |
[
"drug-manufacturers",
"fda",
"health-care",
"prescription-drugs",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Carvedilol |
